🇺🇸 FDA
Patent

US 7964748

Process for preparing intermediates of HMG-CoA reductase inhibitors

granted A61PA61P3/06A61P43/00

Quick answer

US patent 7964748 (Process for preparing intermediates of HMG-CoA reductase inhibitors) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P3/06, A61P43/00